Filter
Reset all

Subjects

Content Types

Countries

AID systems

API

Certificates

Data access

Data access restrictions

Database access

Data licenses

Data upload

Data upload restrictions

Enhanced publication

Institution responsibility type

Institution type

Keywords

Metadata standards

PID systems

Provider types

Quality management

Repository languages

Software

Syndications

Repository types

  • * at the end of a keyword allows wildcard searches
  • " quotes can be used for searching phrases
  • + represents an AND search (default)
  • | represents an OR search
  • - represents a NOT operation
  • ( and ) implies priority
  • ~N after a word specifies the desired edit distance (fuzziness)
  • ~N after a phrase specifies the desired slop amount
  • 1 (current)
Found 5 result(s)

IMEx

The International Molecular Exchange Consortium

Subject(s)
Content type(s)
Country
The IMEx consortium is an international collaboration between a group of major public interaction data providers who have agreed to share curation effort and develop and work to a single set of curation rules when capturing data from both directly deposited interaction data or from publications in peer-reviewed journals, capture full details of an interaction in a “deep” curation model, perform a complete curation of all protein-protein interactions experimentally demonstrated within a publication, make these interaction available in a single search interface on a common website, provide the data in standards compliant download formats, make all IMEx records freely accessible under the Creative Commons Attribution License

Data Buoy Cooperation Panel

DBCP

Subject(s)
Content type(s)
Country
The DBCP is an international program coordinating the use of autonomous data buoys to observe atmospheric and oceanographic conditions, over ocean areas where few other measurements are taken.

European-Mediterranean Seismological Centre

EMSC

Subject(s)
Content type(s)
Country
EMSC collects real time parametric data (source parmaters and phase pickings) provided by 65 seismological networks of the Euro-Med region. These data are provided to the EMSC either by email or via QWIDS (Quake Watch Information Distribution System, developped by ISTI). The collected data are automatically archived in a database, made available via an autoDRM, and displayed on the web site. The collected data are automatically merged to produce automatic locations which are sent to several seismological institutes in order to perform quick moment tensors determination.

World Glacier Monitoring Service

WGMS

Subject(s)
Content type(s)
Country
The World Glacier Monitoring Service (WGMS) collects standardized observations on changes in mass, volume, area and length of glaciers with time (glacier fluctuations), as well as statistical information on the distribution of perennial surface ice in space (glacier inventories). Such glacier fluctuation and inventory data are high priority key variables in climate system monitoring; they form a basis for hydrological modelling with respect to possible effects of atmospheric warming, and provide fundamental information in glaciology, glacial geomorphology and quaternary geology. The highest information density is found for the Alps and Scandinavia, where long and uninterrupted records are available. As a contribution to the Global Terrestrial/Climate Observing System (GTOS, GCOS), the Division of Early Warning and Assessment and the Global Environment Outlook of UNEP, and the International Hydrological Programme of UNESCO, the WGMS collects and publishes worldwide standardized glacier data.

Liverpool COVID-19 Drug Interactions

Subject(s)
Content type(s)
Country
The COVID-19 pandemic has affected every country in the world. It is well documented that those most susceptible to the worst outcomes of COVID-19 are the immunocompromised and those with underlying comorbidities. Therefore, patients requiring treatment for COVID-19 will also be on additional medication, posing a risk for drug-drug interactions (DDIs). In order to address this, the Liverpool Drug Interactions website team developed this freely available drug interactions resource to provide information on the likelihood of interactions between the experimental agents used for the treatment of COVID-19 and commonly prescribed co-medications.